Vernalis Plc - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Vernalis Plc. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Vernalis Plc. The Group's principal activity is to develop and commercialize pharmaceutical products for a range of medical disorders. It has expertise both in de- novo structure and fragment-based drug discovery and pre-clinical and clinical development. The Group has seven product candidates in clinical development (two of which are partnered), two programmes in pre-clinical (one with a partner) and other competitive research programmes. The Group operates in the United Kingdom, Rest of Europe, North America and Rest of the World. On 01-Jul-2008, the Group completed the sale of Apokyn and Vernalis Pharmaceuticals Inc.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report